This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.
S. Anand,
- Professor, Department of Computer Science and Engineering Infant Jesus College of Engineering, Thoothukudi, Tamil Nadu, India
Abstract document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_108631’);});Edit Abstract & Keyword
Alice in Wonderland Syndrome (AIWS) is an uncommon neurological condition characterized by profound distortions in perception. Individuals with AIWS experience altered body image and spatial awareness, often perceiving objects, surroundings, or even their own body as being unusually large, small, or distorted.. The condition presents a unique challenge for both diagnosis and management due to its elusive and varied symptoms. This paper explores how advancements in nanotechnology and biosensor integration can transform the approach to detecting and treating AIWS.
Nanotechnology, with its ability to manipulate matter at the molecular level, offers novel solutions for diagnosing and managing neurological disorders. Nanoparticles can be designed to penetrate the blood-brain barrier, allowing for precise delivery of therapeutic or imaging agents. This capability enhances the treatment of neurological disorders and improves the detection of abnormalities within the brain.. Similarly, biosensors, which can detect biological signals with high specificity and sensitivity, promise to revolutionize real-time monitoring of AIWS symptoms and neurological activity.
By conducting a thorough review of recent literature and experimental research, we emphasize the potential of these emerging technologies in relation to Alice in Wonderland Syndrome (AIWS). Specifically, we explore how nanoparticles could be employed to deliver medications directly to the brain regions impacted by the disorder, thereby reducing side effects and optimizing therapeutic effectiveness. Biosensors could enable continuous monitoring of neurological parameters, allowing for more precise adjustment of treatment strategies and early detection of symptom changes.
Our findings indicate that the integration of nanotechnology and biosensors offers unprecedented opportunities for early detection, precise treatment, and enhanced quality of life for individuals with AIWS. By leveraging these advanced technologies, it is possible to move towards more personalized medicine and targeted therapies, ultimately paving the way for significant advancements in the management of neurological disorders. This research underscores the transformative potential of combining these cutting-edge technologies in the quest to understand and address the complexities of AIWS.
Keywords: Alice in Wonderland Syndrome, nanotechnology, biosensors, neurological disorders, perception distortion, nanoparticles, drug delivery, symptom management, personalized medicine
[This article belongs to Nano Trends – A Journal of Nano Technology & Its Applications (nts)]
S. Anand. Advancements in Nanotechnology and Biosensor Integration for Detection and Treatment of Alice in Wonderland Syndrome. Nano Trends – A Journal of Nano Technology & Its Applications. 2024; 26(03):-.
S. Anand. Advancements in Nanotechnology and Biosensor Integration for Detection and Treatment of Alice in Wonderland Syndrome. Nano Trends – A Journal of Nano Technology & Its Applications. 2024; 26(03):-. Available from: https://journals.stmjournals.com/nts/article=2024/view=0
References
document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_108631’);});Edit
[1] Tunç, Serhat, and Hamit Serdar Başbuğ. “Alice in Wonderland syndrome: a strange visual perceptual disturbance.” Psychiatry and Clinical Psychopharmacology 27.4 (2017): 412-415. [2] Mukherjee, Sudip, et al. “Recent advancements of nanomedicine in neurodegenerative disorders theranostics.” Advanced Functional Materials 30.35 (2020): 2003054. [3] Sudharshan, V.B. (2013). Human like biosensor disease simulator, disease analyzer and drug delivery system. In 2013 IEEE Conference on Information and Communication Technologies, ICT 2013 (pp. 1033–1038). [4] Blom, Jan Dirk. “Alice in Wonderland syndrome: a systematic review.” Neurology: Clinical Practice 6.3 (2016): 259-270. [5] Yokoyama, Tatsushi, et al. “A case of recurrent depressive disorder presenting with Alice in Wonderland syndrome: psychopathology and pre-and post-treatment FDG-PET findings.” BMC psychiatry 17 (2017): 1-6. [6] Krol, Silke, et al. “Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier.” Chemical reviews 113.3 (2013): 1877-1903. [7] Ganji, M.R., & Thakur, M.S. (2004). Microprocessor based biosensors for determination of toxins and pathogens in restricted areas of human intervention. In Proceedings of the International Conference on Artificial Intelligence, IC-AI’04 (Vol. 1, pp. 525-531). [8] Campora, Simona, and Giulio Ghersi. “Recent developments and applications of smart nanoparticles in biomedicine.” Nanotechnology Reviews 11.1 (2022): 2595-2631. [9] Pasqualotto, Emanuele, Stefano Federici, and Marta Olivetti Belardinelli. “Toward functioning and usable brain–computer interfaces (BCIs): A literature review.” Disability and Rehabilitation: Assistive Technology 7.2 (2012): 89-103. [10] Yin, Perry T., et al. “Design, synthesis, and characterization of graphene–nanoparticle hybrid materials for bioapplications.” Chemical reviews 115.7 (2015): 2483-2531. [11] Eswaran, U et al., “Design and Analysis of High Sensitive Microcantilever Based Biosensor for CA 15-3 biomarker detection,” Journal of Applied Science and Computations, 2018, 682-698, ISSN: 1076-5131. DOI:16.10089.JASC.2018.V5I7.453459.0050021 [12] Jena, Bikash Kumar, and C. Retna Raj. “Electrochemical biosensor based on integrated assembly of dehydrogenase enzymes and gold nanoparticles.” Analytical Chemistry 78.18 (2006): 6332-6339. [13] Mudie, Deanna M., Gordon L. Amidon, and Gregory E. Amidon. “Physiological parameters for oral delivery and in vitro testing.” Molecular pharmaceutics 7.5 (2010): 1388-1405. [14] Xu, Yining, et al. “An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers.” Advanced Drug Delivery Reviews 175 (2021): 113795. [15] Frei, Balz, and Jane V. Higdon. “Antioxidant activity of tea polyphenols in vivo: evidence from animal studies.” The Journal of nutrition 133.10 (2003): 3275S-3284S. [16] Belanger, Heather G., et al. “Recent neuroimaging techniques in mild traumatic brain injury.” The Journal of neuropsychiatry and clinical neurosciences 19.1 (2007): 5-20. [17] Conway, James RW, Neil O. Carragher, and Paul Timpson. “Developments in preclinical cancer imaging: innovating the discovery of therapeutics.” Nature reviews cancer 14.5 (2014): 314-328. [18] Stearns, Lisa J., et al. “Assessment of health care utilization and cost of targeted drug delivery and conventional medical management vs conventional medical management alone for patients with cancer-related pain.” JAMA Network Open 2.4 (2019): e191549-e191549. [19] Wilson, George S., and Raeann Gifford. “Biosensors for real-time in vivo measurements.” Biosensors and Bioelectronics 20.12 (2005): 2388-2403. [20] Murali, K., et.al.,(2024). Application of Sensors for Smart Farming. In A. Khang (Ed.), Agriculture and Aquaculture Applications of Biosensors and Bioelectronics (pp. 18-44). IGI Global. https://doi.org/10.4018/979-8-3693-2069-3.ch002
Nano Trends – A Journal of Nano Technology & Its Applications
| Volume | 26 |
| Issue | 03 |
| Received | 19/09/2024 |
| Accepted | 26/09/2024 |
| Published | 22/10/2024 |
function myFunction2() {
var x = document.getElementById(“browsefigure”);
if (x.style.display === “block”) {
x.style.display = “none”;
}
else { x.style.display = “Block”; }
}
document.querySelector(“.prevBtn”).addEventListener(“click”, () => {
changeSlides(-1);
});
document.querySelector(“.nextBtn”).addEventListener(“click”, () => {
changeSlides(1);
});
var slideIndex = 1;
showSlides(slideIndex);
function changeSlides(n) {
showSlides((slideIndex += n));
}
function currentSlide(n) {
showSlides((slideIndex = n));
}
function showSlides(n) {
var i;
var slides = document.getElementsByClassName(“Slide”);
var dots = document.getElementsByClassName(“Navdot”);
if (n > slides.length) { slideIndex = 1; }
if (n (item.style.display = “none”));
Array.from(dots).forEach(
item => (item.className = item.className.replace(” selected”, “”))
);
slides[slideIndex – 1].style.display = “block”;
dots[slideIndex – 1].className += ” selected”;
}